"Designing Growth Strategies is in our DNA"

Asia Pacific Botulinum Toxin Market Size, Share & Industry Analysis, By Application (Therapeutics {Chronic Migraine, Spasticity, Overactive Bladder, Cervical Dystonia, Blepharospasm, and Others}, and Aesthetics {Forehead Wrinkles, Glabellar Lines, Crow's Feet, and Others}), By Type (Botulinum Toxin Type A and Botulinum Toxin Type B), By End-user (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others), and Regional Forecast, 2023-2030

Last Updated: February 24, 2025 | Format: PDF | Report ID: FBI107504

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Overview of the Number of Botulinum Toxin Procedures, By Key Countries
    2. Overview of the Regulatory Scenario, By Key Countries/Regions
    3. Pricing Analysis
    4. Overview of the Types of Botulinum Toxin
    5. Pipeline Analysis, Key Players
    6. Key Industry Developments
    7. Overview of Therapeutic Applications of Botulinum Toxin and Recent Regulatory Approvals
    8. Overview of the Reimbursement Scenario, By Key Countries/Key Regions
    9. Impact of COVID-19 on the Asia Pacific Botulinum Toxin Market
  5. Asia Pacific Botulinum Toxin Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutics
        1. Chronic Migraine
        2. Spasticity
        3. Overactive Bladder
        4. Cervical Dystonia
        5. Blepharospasm
        6. Others
      2. Aesthetics
    2. Market Analysis, Insights and Forecast – By Type
      1. Botulinum Toxin Type A
      2. Botulinum Toxin Type B
    3. Market Analysis, Insights and Forecast – By End-user
      1. Specialty & Dermatology Clinics
      2. Hospitals & Clinics
      3. Others 
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Japan
        1. By Application
      2. China
        1. By Application
      3. India
        1. By Application
      4. Australia
        1. By Application
      5. South Korea
        1. By Application
      6. Southeast Asia
        1. By Application
      7. Rest of Asia Pacific
        1. By Application
  6. Competitive Analysis
    1. Asia Pacific Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. AbbVie Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Ipsen Pharma
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Merz Pharma
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Medytox
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. GALDERMA
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. Lanzhou Institute of Biological Products Co., Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. HUGEL, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Evolus, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Revance Therapeutics, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Supernus Pharmaceuticals, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Table 01: Asia Pacific Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 02: Asia Pacific Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Table 03: Asia Pacific Botulinum Toxin Market Revenue (USD billion) Forecast, By Type, 2019–2030

Table 04: Asia Pacific Botulinum Toxin Market Revenue (USD billion) Forecast, By End User, 2019–2030

Table 05: Asia Pacific Botulinum Toxin Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2030

Table 06: China Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 07: China Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Table 08: India Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 09: India Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Table 10: Japan Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 11: Japan Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Table 12: Australia Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 13: Australia Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Table 14: South Korea Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 15: South Korea Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Table 16: Southeast Asia Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 17: Southeast Asia Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Table 18: Rest of Asia Pacific Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 19: Rest of Asia Pacific Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Asia Pacific Botulinum Toxin Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 109
Consulting Services
    How will you benefit from our consulting services ?